News Category
Regentis Biomaterials strengthens its intellectual property and manufacturing capabilities for GelrinC, advancing its commercialization efforts in Eur...
VERAXA Biotech's collaboration with AI firm Ardigen aims to use artificial intelligence to optimize its oncology pipeline, potentially reducing develo...
VERAXA Biotech's collaboration with AI firm Ardigen aims to enhance its oncology pipeline by using artificial intelligence to identify optimal dual-ta...
Monica Brant, a legendary fitness figure, has become the brand ambassador for N1o1, highlighting the science-backed nitric oxide supplements developed...
Scientists have identified a protein on glioblastoma cells that could be targeted to make the cancer more vulnerable to existing treatments, potential...
Nanox Imaging's subsidiary enters an exclusive UK reseller agreement with Vertec Scientific, expanding access to its FDA-cleared and UKCA/CE-marked AI...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the Democratic Republic of Congo, p...
Helus Pharma appoints Regina Donohue as Chief People Officer and Dr. Suresh Durgam to its Scientific Advisory Board, strengthening its organizational ...
SS Innovations International's record second-quarter revenue and expanding installed base underscore the growing adoption of its SSi Mantra surgical r...
Wolfson Group underscores the mainstreaming of gut microbiome awareness, emphasizing consumer demand for transparency and strain-specific formulation,...
Freyja Healthcare's VereSee™, a mini laparoscope with VisualEntry™, has received FDA clearance, enabling surgeons to visualize during laparoscopic ent...
Discover Healing's free live webinar on Aug. 27 will demonstrate how trapped emotions are released, offering insight into the Emotion Code and its pot...
REPLOID Group AG plans a 1:15 stock split to lower its share price from around 1,700 euros to approximately 113 euros, aiming to make the stock more a...
Helix BioPharma has appointed Dr. Markus Loeffler as Chief Medical Officer to lead the clinical development of L-DOS47 and LEUMUNA, marking a strategi...
SCHOTT Pharma's parent group's updated climate targets, now including a Scope 3 absolute reduction goal, have been validated by the Science Based Targ...
Quantum BioPharma reported significant expense reductions and FDA approval for its Phase 2 trial of Lucid-MS, a potential treatment for progressive mu...
Regentis Biomaterials is simultaneously progressing its GelrinC cartilage repair implant through a pivotal U.S. trial and European commercialization, ...
Dyadic International's new funding round underscores investor confidence in its proprietary protein production platforms, providing capital to advance...
Alpha Cognition's Q2 2026 results show a 71% quarter-over-quarter revenue increase for ZUNVEYL, driven by organic demand and deeper adoption despite l...
Streamex's Q2 2026 financial results and business update call signal its strategic pivot toward commodity tokenization, with the introduction of GLDC ...
The Lung Cancer Foundation of America and the International Association for the Study of Lung Cancer are investing $400,000 in two promising early-car...
PX1 Research's domestically manufactured research peptides now pass a rigorous seven-stage testing protocol, ensuring 99%+ purity and batch-level trac...
Velaris Med Spa introduces provider-led Morpheus8 treatments in Burley, Idaho, bringing advanced RF microneedling for skin tightening to the Magic Val...
Knecht Orthodontics in Mont Belvieu offers Anahuac residents access to advanced orthodontic treatments, including braces and Invisalign, with cutting-...
A comprehensive review provides a structured approach to surgical management of necrotizing enterocolitis in premature infants, emphasizing bowel pres...
Helix BioPharma's board reshuffle, with CEO Thomas Mehrling appointed as director following Janusz Grabski's resignation, aligns governance with strat...
Vycor Medical's second quarter 2026 results show a revenue decline but highlight growing clinical validation for its ViewSite Brain Access System, whi...
Onco-Innovations is building the scientific foundation for its precision oncology drug ONC010, a nanoparticle-encapsulated PNKP inhibitor, through man...
SS Innovations International's record Q2 2026 revenue and growing SSi Mantra installations signal strong demand for affordable robotic surgery, with F...
Regentis Biomaterials has secured a Japanese patent for its organic solvent-free manufacturing process and liquid formulation of GelrinC, boosting its...
Regentis Biomaterials' GelrinC, a cell-free hydrogel implant, gains European approval for a scalable manufacturing process and progresses U.S. trials,...
Gaxos.ai's warrant exercise agreement, expected to generate $3.6 million, signals investor confidence and provides capital to advance its AI-driven so...
Researchers at the University of Manchester discovered that a subset of immune cells, previously overlooked, plays a crucial role in orchestrating and...
Quantum BioPharma reported a 53% reduction in operating expenses and received FDA approval for its Phase 2 trial of Lucid-MS, a potential treatment fo...
Regentis Biomaterials accelerates GelrinC's path to market by simultaneously progressing US Phase III trials and European commercialization, potential...
HeartBeam reports Q2 2026 progress in its heart attack detection program and initial commercial launch, with cash runway extended into 2027.
Lantern Pharma's Q2 2026 results show significant pipeline progress and strategic moves, including the establishment of Open Medicine AI as a separate...
Redwood AI Corp. has finalized its acquisition of Quantum.IQ Technologies, integrating a post-quantum cryptography platform to address emerging quantu...
Helus Pharma's Phase 3 program for HLP003 in major depressive disorder is on track with enrollment completed in the first pivotal study, positioning t...
DM Clinical Research celebrates its 20th anniversary, highlighting its growth into a leading clinical research network with over 35 sites and 35,000 p...
Burcon's first-quarter fiscal 2027 results show accelerating commercialization with revenue up 273% year-over-year, but the company faces a substantia...
NeOnc Technologies' NEO100 met its primary endpoint in a Phase 2a trial for recurrent brain cancer, showing significant survival benefits and tolerabi...
PX1 Research's new batches of retatrutide and tirzepatide peptides, manufactured under cGMP and verified by HPLC, meet high purity standards, supporti...
Quantum BioPharma is developing Lucid-MS, a therapy aimed at inhibiting myelin degradation and preserving myelin, to address progression independent o...
Carolina Age Management Institute has rebranded as Cami Aesthetics, unifying its two North Carolina locations under a new identity focused on clinical...
GeoVax offers its MVA-based hemorrhagic fever vaccine expertise and candidates to aid the global response to the fast-growing Bundibugyo Ebola outbrea...
SS Innovations International's record Q2 revenue and growing installation base highlight the increasing adoption of its SSi Mantra surgical robot, pos...
Amidst looming tariffs on drug imports, global pharmaceutical companies are investing approximately $500 billion in US operations, a move that could r...
